Enjoy complimentary customisation on priority with our Enterprise License!
The immunosuppressants market share is expected to increase to USD 6.99 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.73%.
This immunosuppressants market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers immunosuppressants market segmentations by drug class (corticosteroids, monoclonal antibodies, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The immunosuppressants market report also offers information on several market vendors, including AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc. among others.
Download the Free Report Sample to Unlock the Immunosuppressants Market Size for the Forecast Period and Other Important Statistics
Immunosuppressants stop your immune system from damaging healthy cells and tissues. People with organ transplants and stem cell transplants take these medicines to prevent transplant rejections. Some of these drugs are used to make the body less likely to reject a transplanted organ, such as a liver, heart, or kidney. These drugs are also called as antirejection drugs. Other immunosuppressant drugs are often used to treat autoimmune disorders such as lupus, psoriasis, and rheumatoid arthritis.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the immunosuppressants market encompasses successful business strategies deployed by the key vendors. The immunosuppressants market is concentrated and the vendors are deploying organic and inorganic growth strategies to compete in the market.
The reimbursement policies for kidney transplantation is notably driving the immunosuppressants market growth, although factors such as side effects of immunosuppressants may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the immunosuppressants industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Immunosuppressants Market Driver
Key Immunosuppressants Market Trend
Key Immunosuppressants Market Challenge
This immunosuppressants market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global immunosuppressants market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the immunosuppressants market during the forecast period.
To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The immunosuppressants market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
38% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the immunosuppressants market in North America. Market growth in this region will be slower than the growth of the market in Asia and Europe.
A rise in the number of organ transplants and technological advancement in the healthcare sector coupled with massive investment in research and development will facilitate the immunosuppressants market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 pandemic in 2020 had a negative impact on the regional market. However, in 2021, the demand for these products rebounded as manufacturing activities resumed due to COVID-19 vaccination drives. These factors will thus drive the growth of the regional immunosuppressants market growth during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The immunosuppressants market share growth by the corticosteroids segment will be significant during the forecast period. Corticosteroids are used as a first-line treatment of autoimmune hemolytic anemia. Patients with autoimmune hemolytic anemia are mostly treated with low doses of corticosteroids. Patients receiving low doses of corticosteroids for more than six months have a lower incidence of relapse. Hence, the increasing prevalence of autoimmune diseases across the globe is expected to increase the demand for corticosteroids and, thereby, contribute to the growth of the market in focus during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the immunosuppressants market size and actionable market insights on the post-COVID-19 impact on each segment.
Our report provides extensive information on the value chain analysis for the immunosuppressants market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
You may be interested in:
Organ Transplant Immunosuppressant market - Market share will grow at a CAGR of close to 4% during 2017-2021???.
Immunosuppressants Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.73% |
Market growth 2022-2026 |
$ 6.99 billion |
Market structure |
Concentrated |
YoY growth (%) |
5.3 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
AbbVie Inc., Accord Healthcare Ltd., Astellas Pharma Inc., Belcher Pharmaceuticals LLC, Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, LEO Pharma AS, Livzon Pharmaceutical Group Inc., Novartis AG, Pfizer Inc., RPG Life Sciences Ltd., Sanofi, Sebela Pharmaceuticals Inc., TFF Pharmaceuticals Inc., and Viatris Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.